The Role of Omega 9 Fatty Acids in Lipid Injectable Emulsions (ILE)

Jul 22, 2020 04:00pm -
Jul 22, 2020 05:30pm

Event Description

The Role of Omega 9 Fatty Acids in Lipid Injectable Emulsions (ILE)
July 22, 2020 
Time:  4:00 PM– 5:30 PM ET


Omega-9 fatty acids are the differentiating fatty acid in the newest ILE on the US market. Clinicians are challenged to determine the most appropriate ILE for their patient. To do so it is essential to have a strong understanding of the attributes of the key fatty acids: omega- 3, 6 and 9 and the literature that support their safety and efficacy.  This webinar will focus on providing the clinician an understanding of omega-9 fatty acids and the literature that supported its FDA approval in ILE products.


Learning Objectives:

  • Identify the characteristics of omega-9 fatty acids
  • Outline how omega-9 fatty acids differ from omega- 3 and 6 fatty acids and what benefit or disadvantage they may bring to an ILE
  • Summarize the clinical evidence supporting the efficacy and safety of the omega-9 fatty containing ILEs

Understanding Omega- 9 Fatty Acids: How are they Unique?
Gary P. Zaloga, MA, MD, Chief Medical Officer, MedSciHealth Consultants, Bradenton, Florida


What is the clinical evidence for Omega-9 fatty acids containing ILE? 
Mark DeLegge, MD, DeLegge Medical, Charleston, South Carolina


Moderator: Todd W. Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP, FASPEN, Clinical Pharmacy Services Manager & Nutrition Support Team Coordinator, University of Texas MD Anderson Cancer Center, Houston, TX

Free non-CE webinar.
This webinar is supported by 

Event Type:Education
Early registration ends on Jul 16, 2020.
Regular registration starts on Jul 17, 2020 and ends on Jul 21, 2020.
Late registration starts on Jul 22, 2020.